Standout Papers

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Respons... 2009 2026 2014 2020 2.3k
  1. Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria (2009)
    Jedd D. Wolchok, Axel Hoos et al. Clinical Cancer Research
  2. Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study (2009)
    Jedd D. Wolchok, Bart Neyns et al. The Lancet Oncology
  3. Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations (2016)
    Axel Hoos Nature Reviews Drug Discovery
  4. Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma (2013)
    Jedd D. Wolchok, F. Stephen Hodi et al. Annals of the New York Academy of Sciences

Immediate Impact

57 by Nobel laureates 13 from Science/Nature 167 standout
Sub-graph 1 of 16

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Theranostic Fluorescent Probes
2024 Standout

Works of Axel Hoos being referenced

Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
2016
Big opportunities for small molecules in immuno-oncology
2015

Author Peers

Author Last Decade Papers Cites
Axel Hoos 9043 4629 3390 141 13.1k
Aurélien Marabelle 9849 5586 2635 272 14.5k
Joseph P. Eder 8093 2845 3395 176 12.0k
Patrick A. Ott 10963 5386 3457 236 15.1k
José Luis Perez‐Gracia 10257 5582 2763 207 14.9k
Laura Q.M. Chow 8861 2951 2795 156 12.1k
Christian U. Blank 10302 6432 4868 267 14.3k
Bart Neyns 9568 4325 4159 310 13.5k
Michael A. Postow 11833 5121 2801 227 14.9k
Leisha A. Emens 10452 5914 2819 166 14.1k
Jason J. Luke 7975 4708 4577 290 12.6k

All Works

Loading papers...

Rankless by CCL
2026